| 发明名称 |
THE USE OF THYMOSIN ALPHA 1 TO REDUCE THE SIDE EFFECTS OF CHEMOTHERAPY IN CANCER PATIENTS |
| 摘要 |
A method for reducing the severity of chemotherapy side effects in cancer patients by administering thymosin .alpha.1 in conjunction with the administration of a chemotherapy agent to the patient. As a result of the reduction of post-chemotherapy side effects, patients experience an increase in the quality of life.
|
| 申请公布号 |
CA2407238(C) |
申请公布日期 |
2012.03.13 |
| 申请号 |
CA20012407238 |
申请日期 |
2001.04.19 |
| 申请人 |
SCICLONE PHARMACEUTICALS, INC. |
发明人 |
RUDOLPH, ALFRED R.;TAM, VINCENT CHUNG-YIN;QUAN, MAGGIE JIE |
| 分类号 |
A61K38/22;A61K45/00;A61K31/00;A61K31/131;A61K31/505;A61K31/56;A61K31/573;A61K33/00;A61K33/18;A61K33/42;A61K38/00;A61P1/00;A61P1/08;A61P25/00;A61P25/24;A61P35/00 |
主分类号 |
A61K38/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
